NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Operating Margin in % from Q4 2012 to Q4 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2012 to Q4 2022.
  • Navidea Biopharmaceuticals, Inc. Operating Margin for the quarter ending December 31, 2022 was -21.4K %, a 843% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Operating Margin for 2022 was -21.4K %, a 843% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Operating Margin for 2021 was -2.27K %, a 93.8% decline from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Operating Margin for 2020 was -1.17K %, a 29.8% increase from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -21.4K -19.1K -843% Oct 1, 2022 Dec 31, 2022
Q3 2022 -12.6K -11K -684% Jul 1, 2022 Sep 30, 2022
Q2 2022 -5.86K -4.52K -337% Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.87K -1.58K -123% Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.27K -1.1K -93.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.6K -291 -22.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.34K +46.3 +3.34% Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.29K +162 +11.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -1.17K +496 +29.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.31K +269 +17% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.39K +303 +17.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.45K -296 -25.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.67K -739 -79.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.58K -738 -87.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -1.69K -937 -124% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.15K -276 -31.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -928 -161 -21% Oct 1, 2018 Dec 31, 2018
Q3 2018 -842 -286 -51.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -754 -454 -152% Apr 1, 2018 Jun 30, 2018
Q1 2018 -878 -671 -324% Jan 1, 2018 Mar 31, 2018
Q4 2017 -767 -562 -276% Oct 1, 2017 Dec 31, 2017
Q3 2017 -556 -1.07K -207% Jul 1, 2017 Sep 30, 2017
Q2 2017 -299 +9.12K +96.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -207 +633 +75.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -204 +408 +66.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 518 +799 Jul 1, 2016 Sep 30, 2016
Q2 2016 -9.42K -9.03K -2362% Apr 1, 2016 Jun 30, 2016
Q1 2016 -840 -87.6 -11.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -612 +733 +54.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -281 +505 +64.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -383 +1.09K +74.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -753 +1.37K +64.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -1.35K +2.05K +60.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -785 +4.59K +85.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.48K +14.1K +90.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -2.13K +40.5K +95% Jan 1, 2014 Mar 31, 2014
Q4 2013 -3.4K +32.1K +90.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -5.38K Jul 1, 2013 Sep 30, 2013
Q2 2013 -15.6K Apr 1, 2013 Jun 30, 2013
Q1 2013 -42.6K Jan 1, 2013 Mar 31, 2013
Q4 2012 -35.5K Oct 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.